Lasa Supergenerics Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Omkar Herlekar, was filed 01 Apr 2023.
Lasa Supergenerics Limited: what insiders have been doing
Lasa Supergenerics Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). Nothing new has been filed by managers of Lasa Supergenerics Limited in twelve months, the latest record being from 1 April 2023.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 9,071,429 shares@ ₹40.0465.1% of flowEquity SharesSEBI:ca48b3ebdb40a5a371c70bdf8676a8b973c80d59Canonical exit: 7 May 2023 (T+90)
- 58,500 shares@ ₹22.0015.4% of flowEquity SharesSEBI:9c872df38cc6740fdb0779e8c01e3da58477b01d
- 185,714 shares@ ₹40.04100.0% of flowEquity SharesSEBI:03a732dd603ce0f9e4a5c5ad08461793a2d6b9c8Canonical exit: 7 May 2023 (T+90)
- 171,428 shares@ ₹40.0484.6% of flowEquity SharesSEBI:234337685828348fa9c5fe9a8e52ba6818e98093Canonical exit: 5 Apr 2023 (T+90)
- 700,343 shares@ ₹29.45844.1% of flowEquity SharesSEBI:e0dc1dd812b4e568e0c8041c02be28a70b005633
- 2,159,879 shares@ ₹74.5430.9% of flowEquity SharesSEBI:e69f32a9cca2a91df7fa445cb55485ca781f3e10
6 of 6 declarations
About Lasa Supergenerics Limited
Lasa Supergenerics Limited is a company engaged in the manufacturing of generic pharmaceutical products. It primarily operates in the Indian market and focuses on both human and animal health segments.
